SINOVAC BIOTECH LTD Income (Loss) from Equity Method Investments
SINOVAC BIOTECH LTD (SVA) reported Income (Loss) from Equity Method Investments of -$4.04 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-06-05
| Period end | Income (Loss) from Equity Method Investments 12 month |
|---|---|
| 2025-12-31 | -$4.04M 20-F · filed 2026-06-05 |
| 2024-12-31 | -$2.70M 20-F · filed 2026-06-05 |
| 2023-12-31 | -$11.46M 20-F · filed 2026-04-30 |
| 2022-12-31 | $7.76M 20-F · filed 2026-04-30 |
| 2021-12-31 | $2.63M 20-F · filed 2026-04-30 |